These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34071586)

  • 1. Risk of Respiratory Infectious Diseases and the Role of Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Cohort Study.
    Li DJ; Chen YL; Hsiao RC; Chen HL; Yen CF
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate and the risk of burn injury among children with attention-deficit/hyperactivity disorder.
    Chen VC; Yang YH; Yu Kuo T; Lu ML; Tseng WT; Hou TY; Yeh JY; Lee CT; Chen YL; Lee MJ; Dewey ME; Gossop M
    Epidemiol Psychiatr Sci; 2020 Jul; 29():e146. PubMed ID: 32686635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.
    Ho HY; Wong CK; Wu SY; Hsiao RC; Chen YL; Yen CF
    Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33535410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS; Chen SJ; Chou WJ; Cheng H; Tang CS; Chang HL; Tzang RF; Wu YY; Huang YF; Chou MC; Liang HY; Hsu YC; Lu HH; Huang YS
    J Clin Psychiatry; 2008 Jan; 69(1):131-40. PubMed ID: 18312048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.
    Liao YT; Yang YH; Kuo TY; Liang HY; Huang KY; Wang TN; Lee Y; McIntyre RS; Chen VC
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):279-288. PubMed ID: 28856464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan.
    Chien WC; Chung CH; Lin FH; Yeh CB; Huang SY; Lu RB; Chang HA; Kao YC; Chiang WS; Chou YC; Tsao CH; Wu YF; Tzeng NS
    Res Dev Disabil; 2017 Jun; 65():57-73. PubMed ID: 28458048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
    Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
    J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.
    Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Huang TS; Chou WJ; Chou MC; Lee MJ; Lee TL; Shyu YC
    Epidemiol Psychiatr Sci; 2017 Dec; 26(6):624-634. PubMed ID: 27435692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
    Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study.
    Liang SH; Yang YH; Kuo TY; Liao YT; Lin TC; Lee Y; McIntyre RS; Kelsen BA; Wang TN; Chen VC
    Res Dev Disabil; 2018 Jan; 72():96-105. PubMed ID: 29121517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
    Shin JY; Roughead EE; Park BJ; Pratt NL
    BMJ; 2016 May; 353():i2550. PubMed ID: 27245699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
    Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy May Attenuate the Risk of Child Abuse in Attention-Deficit/Hyperactivity Disorder from the Real-World Evidence.
    Lin CC; Chung CH; Chien WC; Tzeng NS
    J Child Adolesc Psychopharmacol; 2023 Mar; 33(2):59-68. PubMed ID: 36944094
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.